ProShare Advisors’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $53.3M | Sell |
|
|||||
|
2021
Q1 | $44.6M | Buy |
|
|||||
|
2020
Q4 | $40.3M | Buy |
|
|||||
|
2020
Q3 | $26.2M | Buy |
|
|||||
|
2020
Q2 | $22.6M | Buy |
|
|||||
|
2020
Q1 | $16.7M | Sell |
|
|||||
|
2019
Q4 | $26.6M | Buy |
|
|||||
|
2019
Q3 | $22.2M | Buy |
|
|||||
|
2019
Q2 | $28.8M | Sell |
|
|||||
|
2019
Q1 | $33.4M | Buy |
|
|||||
|
2018
Q4 | $23.9M | Buy |
|
|||||
|
2018
Q3 | $30.7M | Sell |
|
|||||
|
2018
Q2 | $30.4M | Sell |
|
|||||
|
2018
Q1 | $29.9M | Buy |
|
|||||
|
2017
Q4 | $31.2M | Buy |
|
|||||
|
2017
Q3 | $29.2M | Buy |
|
|||||
|
2017
Q2 | $25M | Buy |
|
|||||
|
2017
Q1 | $21.2M | Sell |
|
|||||
|
2016
Q4 | $24M | Buy |
|
|||||
|
2016
Q3 | $21M | Sell |
|
|||||
|
2016
Q2 | $23.3M | Buy |
|
|||||
|
2016
Q1 | $27.1M | Sell |
|
|||||
|
2015
Q4 | $45.9M | Buy |
|
|||||
|
2015
Q3 | $35.5M | Sell |
|
|||||
|
2015
Q2 | $42.5M | Sell |
|
|||||
|
2015
Q1 | $41.6M | Buy |
|
|||||
|
2014
Q4 | $36.2M | Buy |
|
|||||
|
2014
Q3 | $24.1M | Sell |
|
|||||
|
2014
Q2 | $29.9M | Sell |
|
|||||
|
2014
Q1 | $35.1M | Buy |
|
|||||
|
2013
Q4 | $18.2M | Buy |
|
|||||
|
2013
Q3 | $10.6M | Sell |
|
|||||
|
2013
Q2 | $8.71M | Buy |
|